VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Proteasome inhibition as a therapeutic strategy for hematologic malignancies.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Proteasome inhibition as a therapeutic strategy for hematologic malignancies.
Proteasome inhibition as a therapeutic strategy for hematologic malignancies. Expert Rev Anticancer Ther. 2005 Jun; 5(3):465-76.
View in:
PubMed
subject areas
Boronic Acids
Bortezomib
Clinical Trials as Topic
Hematologic Neoplasms
Humans
Protease Inhibitors
Proteasome Endopeptidase Complex
Pyrazines
Ubiquitin
authors with profiles
NICHOLAS MITSIADES, M.D.